Abstract
We have designed, synthesized, and characterized a library of 38 novel flavonoid compounds linked with amines. Some of these amine-linked flavonoids have potent in vitro activity against parasites that cause cutaneous leishmaniasis, a tropical disease endemic in 80 countries worldwide. The most promising candidate, FM09h, was highly active, with a 50% inhibitory concentration (IC50) of 0.3mM against Leishmania amazonensis, L. tropica, and L. braziliensis amastigotes. It was metabolically stable, with 39% and 66% of FM09h remaining after 30-minute incubation with human and rat liver microsomes, respectively. In L. amazonensis LV78 cutaneous leishmaniasis mouse model, intralesional injection of FM09h (10mg/kg, once every 4 days for 8 times) demonstrated promising effect in reducing the footpad lesion thickness by 72%, displaying an efficacy comparable to that of sodium stibogluconate (SSG) (63%).
Original language | English |
---|---|
Article number | e02165-20 |
Journal | Antimicrobial Agents and Chemotherapy |
Volume | 65 |
Issue number | 5 |
DOIs | |
Publication status | Published - May 2021 |
Keywords
- Amastigote
- Antileishmanial
- Bioflavonoids
- Cutaneous leishmaniasis
- Flavonoids
- Leishmania
- Promastigote
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases